Could melatonin promote healthy ageing?

By Tim Cutcliffe contact

- Last updated on GMT

© iStock/ aquarius 83men
© iStock/ aquarius 83men

Related tags: Melatonin, Circadian rhythm, Sleep

Lack of melatonin has been widely linked to sleep disorders and disturbances in the human circadian rhythm or body clock. But the hormone may also benefit sleep-related aspects of other conditions, say researchers.

The robustness of the circadian system decreases with age and in certain diseases, together with a decline in melatonin production, notes the review published in the British Journal of Pharmacology. However, evidence suggests that supplementing the hormone might assist mitigate these effects.

Melatonin supplementation has helped adult insomniacs fall asleep quicker, and realignment in sleep cycles to the normal dark/light pattern in blind people with sleep-wake disorder, reports author, Dr. Nava Zisapel from the George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel.

Prolonged-release melatonin (PRM) has also been shown to lower nocturnal blood pressure (BP) in ‘non-dippers’ (individuals whose BP does not follow the normal night-time reduction). The risk of cardiovascular events is significantly higher in such people.

Additionally, a recent meta-analysis has strengthened previous evidence that melatonin may be effective in improving sleep problems in children with Autistic Spectrum Disorder.

“Clinically meaningful effects of melatonin treatment have been demonstrated in placebo-controlled trials in humans, particularly in disorders associated with diminished or misaligned melatonin rhythms,” ​explained Zisapel.

“The ability of exogenously administered melatonin to mitigate the loss of the endogenous night signal and improve the restorative value of sleep, represents a promising investigational route for early intervention to promote healthy physical and mental ageing,” ​he added.

Application in Alzheimer’s?

Melatonin has also attracted attention in the area of Alzheimer’s Disease (AD).

Researchers have identified associations between insomnia and neurodegenerative diseases such as AD. The build-up of beta-amyloid plaque in pre-clinical AD has been correlated with poor sleep quality, while early neuropathological changes at this stage of AD are accompanied by lower melatonin levels.  

Scientists have also identified a possible mechanism whereby sleep disruption may reduce the capability of clearing the toxic beta-amyloid plaques, particularly in an area of the brain known as the precuneus. (Activation of the precuneus is involved in the speed of reaction time to a verbal memory task).

One intervention study helped maintain or improve cognitive function in mild-moderate AD patients using 2milligrams/ day (mg/d) of PRM over 6 months. However, randomised controlled trials (RCTs) using the immediate-release form of the supplement, have not demonstrated efficacy.

Nevertheless, the balance of evidence to-date therefore warrant furthers research in this area, suggests Zisapel.

“The ability of melatonin to improve the restorative value of sleep, through its effects on the circadian clock and reduced activation of the precuneus, open new perspectives to the role of clock and sleep disturbances in AD pathophysiology.

“The relationship between these effects, attenuated beta-amyloid overproduction and enhanced clearance of accumulated amyloid to decrease beta-amyloid load in this region, warrant further investigation’​ he concludes.

Competing interest

Zisapel is the founder and Chief Scientific Officer of Neurim Pharmaceuticals, the company that developed and produces prolonged release melatonin-Circadin®.

Source: British Journal of Pharmacology
Published online, doi: 10.1111/bph.14116
“New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation”
Author: Nava Zisapel

Related news

Show more

Related products

show more

Happier with indication-specific probiotics

Happier with indication-specific probiotics

Winclove Probiotics | 07-Jun-2022 | Product Brochure

From the very founding of Winclove Probiotics, our aim to help people, society, and the world has been an essential part of our business DNA.

Stronger Bones Begin with MenaQ7® Vitamin K2

Stronger Bones Begin with MenaQ7® Vitamin K2

Gnosis by Lesaffre | 06-Jun-2022 | Infographic

By activating the K-dependent protein Osteocalcin, Vitamin K2 as MK-7 enables the body to properly utilize calcium, binding it to the bone matrix.

Botanicals you can rely on, from ADM

Botanicals you can rely on, from ADM

ADM | 02-Jun-2022 | Product Brochure

Today more than ever, consumers are striving to support their overall well-being in a convenient way, with foods, beverages and dietary supplements that...

DurOmega® Algal DHA 20% water dispersible powder

DurOmega® Algal DHA 20% water dispersible powder

INNOBIO Corporation Limited | 30-May-2022 | Technical / White Paper

INNOBIO most recently launched a new product DurOmega® Algal DHA 20% water dispersible powder with significantly reduced fishy odor and taste, which optimizes...

Related suppliers

Follow us

Products

View more

Webinars